These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 39307764)
1. [Pharmacovigilance guidelines for clinical application of traditional Chinese medicine injections]. Fu CK; Liu H; Wang LX; Zou YH; Li MQ; Lin YM; Sun WH; Wei X; Hu YE; Xie YM; Li YY Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4279-4284. PubMed ID: 39307764 [TBL] [Abstract][Full Text] [Related]
2. [Pharmacovigilance guidelines for clinical application of Chinese patent medicines for mucosal administration]. Zhao XX; Hua H; Li YY; Wang ZF; Liu FM; Wei RL; Cui X; Yang S; Wang LX; Xie YM Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4291-4297. PubMed ID: 39307766 [TBL] [Abstract][Full Text] [Related]
3. [Pharmacovigilance guidelines for clinical application of oral Chinese patent medicines]. Wang LX; Yang S; Wei RL; Li YY; Cui X; Zhao XX; Peng WX; Liu FM; Wang MM; Li XH; Wang ZF; Xie YM Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4273-4278. PubMed ID: 39307763 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacovigilance guidelines of Chinese patent medicines]. Wang LX; Wang MM; Li YY; Wang ZF; Cui X; Zhao XX; Liu FM; Yang S; Wei RL; Wang YX; Zhang B; Xie YM Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4261-4265. PubMed ID: 39307761 [TBL] [Abstract][Full Text] [Related]
5. Traditional Chinese medicine and drug-induced anaphylaxis: data from the Beijing pharmacovigilance database. Li X; Thai S; Lu W; Sun S; Tang H; Zhai S; Wang T Int J Clin Pharm; 2018 Aug; 40(4):921-927. PubMed ID: 30051226 [TBL] [Abstract][Full Text] [Related]
6. [Guidelines for construction of traditional Chinese medicine pharmacovigilance system in medical institutions]. Liu FM; Zhang L; Li YY; Wang ZF; Zhao XX; Cui X; Wei RL; Yang S; Wang LX; Xie YM Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4266-4272. PubMed ID: 39307762 [TBL] [Abstract][Full Text] [Related]
7. [Necessity of applying pharmacovigilance in post-marketing safety monitoring of traditional Chinese medicine injections]. Wang HN; Chen W; Fu Z; Du WM; He J Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):612-4. PubMed ID: 18536393 [TBL] [Abstract][Full Text] [Related]
8. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective. Zhang L; Yan J; Liu X; Ye Z; Yang X; Meyboom R; Chan K; Shaw D; Duez P J Ethnopharmacol; 2012 Apr; 140(3):519-25. PubMed ID: 22374080 [TBL] [Abstract][Full Text] [Related]
9. Traditional Chinese herbal injection: Current status and future perspectives. Li H; Wang S; Yue Z; Ren X; Xia J Fitoterapia; 2018 Sep; 129():249-256. PubMed ID: 30059719 [TBL] [Abstract][Full Text] [Related]
10. [Safety evaluation of traditional Chinese medicine injections and study of related key technology]. Cheng F; Liu Z Zhongguo Zhong Yao Za Zhi; 2009 Apr; 34(8):1052-4. PubMed ID: 19639795 [TBL] [Abstract][Full Text] [Related]
11. Safety profile of traditional Chinese herbal injection: An analysis of a spontaneous reporting system in China. Li H; Deng J; Deng L; Ren X; Xia J Pharmacoepidemiol Drug Saf; 2019 Jul; 28(7):1002-1013. PubMed ID: 31131950 [TBL] [Abstract][Full Text] [Related]
12. [Pharmacovigilance of Chinese medicine: practice of cognition, application, prevention and rescue of drug toxicity]. Zhang B; Lin ZJ; Zhang XM Zhongguo Zhong Yao Za Zhi; 2017 May; 42(10):2017-2020. PubMed ID: 29090566 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacovigilance guidelines for clinical application of Chinese patent medicines for external use]. Cui X; Yang DQ; Xie ZN; Li YY; Wang ZF; Liu H; Liu FM; Zhao XX; Lu ZK; Wang LX; Xie YM Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4285-4290. PubMed ID: 39307765 [TBL] [Abstract][Full Text] [Related]
14. [Discussion on establishment of quality control system for intensive hospital monitoring on traditional Chinese medicine injections]. Jiang JJ; Xie YM Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2689-91. PubMed ID: 23285909 [TBL] [Abstract][Full Text] [Related]
15. [Consideration on establishing evaluation system of clinical practice guidelines in traditional Chinese medicine]. Bai X; Liu JP; Guo YB; Feng X; Fang SN; Yang SH; Guan YJ; Chen W Zhongguo Zhong Yao Za Zhi; 2020 Apr; 45(7):1596-1599. PubMed ID: 32489037 [TBL] [Abstract][Full Text] [Related]
16. Considerations for the Quality Control of Newly Registered Traditional Chinese Medicine in China: A Review. Qu J; Zhang T; Liu J; Su Y; Wang H J AOAC Int; 2019 May; 102(3):689-694. PubMed ID: 30381092 [No Abstract] [Full Text] [Related]
17. [Retrospective analysis and discussion on 74 cases of adverse reactions of traditional Chinese medicine injection]. Wang Y; Fan LP; Song J; Cai YP; Jinang TT; Wang YG; Kong XW; Wu JR Zhongguo Zhong Yao Za Zhi; 2018 Nov; 43(21):4347-4351. PubMed ID: 30583639 [TBL] [Abstract][Full Text] [Related]
18. [Guidelines for quality control of human use experience study on traditional Chinese medicine]. Tang YQ; Yang ZQ; Tang ZA; Yuan WA; Tang JY; Zou C Zhongguo Zhong Yao Za Zhi; 2024 Sep; 49(17):4801-4804. PubMed ID: 39307814 [TBL] [Abstract][Full Text] [Related]
19. [Thoughts and suggestions on registration and classification of traditional Chinese medicines]. Tang JY Zhongguo Zhong Yao Za Zhi; 2020 Aug; 45(16):4004-4008. PubMed ID: 32893601 [TBL] [Abstract][Full Text] [Related]
20. [Pharmacovigilance of traditional Chinese medicine according to theory of preventive treatment of disease]. Ri-Na SA; Bing Z Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(17):4273-4276. PubMed ID: 33164414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]